synchronized chemoradiotherapy , in which alkaloid and alkyl agents are used to accumulate cells into the radiosensitive g2 and m phases , was developed for the treatment of malignant gliomas in 1976 and significant improvement in survival has been reported .
C0007634
cells
C0007591
m phases